Ethnobotany: Intellectual Property and Bioprospecting

Ethnobotany is a fascinating field that explores the relationship between people and plants. However, this interaction often raises complex questions, especially when it comes to intellectual property and bioprospecting. Understanding the ethical, legal, and economic dimensions is crucial for students studying this dynamic area. This article provides a comprehensive overview of these critical issues, including key definitions, international agreements, and real-world case studies.

Unpacking Ethnobotany: Intellectual Property and Bioprospecting

Socioethnobotany is a core concept, focusing on compensating indigenous peoples for sharing their invaluable ethnobotanical knowledge. Bioprospecting involves collecting plants, animals, or microorganisms, alongside indigenous knowledge, to discover new genetic or biochemical resources for crops, drugs, or industrial chemicals. Unfortunately, this can sometimes lead to biopiracy, which is the unethical or illegal appropriation of indigenous knowledge, often through patents, without proper compensation.

A patent grants exclusive rights to an inventor for a fixed period in exchange for public disclosure of a new, inventive, and industrially applicable invention. Historically, indigenous knowledge, chemical structures, and genes were often viewed as common property, leading to significant challenges in intellectual property rights for indigenous cultures.

Key International Agreements and Declarations

Several international frameworks aim to regulate bioprospecting and ensure fair practices:

• Declaration of Belém (1988): Issued by the First International Congress of Ethnobiology, it advocates for development aid in ethnobiological inventory, conservation, and management. It emphasizes recognizing indigenous specialists, guaranteeing human rights, compensating native peoples for their knowledge and resources, and making research results available to native communities.
• Manila Declaration (1992): This declaration on Botanical Collecting Ethics highlights collaboration, information sharing, and compensation. It recommends working with local scientists, sending reports to host institutions, depositing duplicates in national museums, and including travel costs for local counterparts when applying for funds.
• Convention on Biological Diversity (CBD, 1993): Emerging from the Earth Summit in Rio, the CBD has three main objectives: conservation of biological diversity, sustainable use of its components, and fair and equitable sharing of benefits from genetic resources. Signed by 140 nations, it laid the groundwork for international cooperation.
• Nagoya Protocol (2010): A supplementary agreement to the CBD, it focuses on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization. Its three pillars are Access, Benefit Sharing, and Compliance. The Access and Benefit-Sharing Clearing-House (ABSCH) serves as a platform for information exchange.
• Cartagena Protocol (2000): This international treaty governs the transboundary movement of living modified organisms resulting from modern biotechnology, serving as a supplementary agreement to the CBD.

The Rise and Decline of Bioprospecting

In the 1980s and early 1990s, there was a significant push to promote rainforests as sources of potential medicines. This concept linked conservation with economic reasons, aiming to find valuable products and resolve poverty in indigenous communities. Multimillion-dollar grants were awarded to collect organisms for drug screening.

For example, in 1991, Merck made a pioneering $1 million deal with the Costa Rican government to explore biodiversity in its national parks. However, a